Csl Behring Gmbh competitive analysis

Explore patent oppositions filed by Csl Behring Gmbh against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Aug 27, 2026
Patent NumberTitleApplicantOpposition Date
Method For Preparing Human Plasma ProteinsLABORATOIRE FRANAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIESMay 27, 2020
C1-Inh Compositions And Methods For The Prevention And Treatment Of Disorders Associated With C1 Esterase Inhibitor DeficencySHIRE VIROPHARMAMar 28, 2018
Oligopeptide-Free Cell Culture MediaBAXALTAJan 18, 2018

Explore Csl Behring Gmbh's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 27, 2026
Patent NumberPublication DateTitleTotal Oppositions
Mar 17, 2021Proteolytically Cleavable Fusion Proteins With High Molar Specific Activity2
Mar 13, 2019Proteolytically Cleavable Fusion Protein Comprising A Blood Coagulation Factor1

Latest PTAB cases involving Csl Behring Gmbh

Discover the latest PTAB cases involving Csl Behring Gmbh, highlighting their recent legal challenges and patent disputes.

Last updated on: Aug 26, 2026
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Csl Behring Gmbh

IPR2019-00459Dec 21, 2018CSL BEHRING GMBHSHIRE VIROPHARMA INCORPORATEDInstitution Denied
IPR2018-01345Jul 6, 2018CSL BEHRING GMBHBIOVERATIV THERAPEUTICSInstitution Denied
IPR2018-01345Jul 6, 2018CSL BEHRING GMBHBIOVERATIV THERAPEUTICS INC.Institution Denied
IPR2018-01345Jul 6, 2018CSL BEHRING GMBHPIERCEInstitution Denied
IPR2018-01313Jul 2, 2018CSL BEHRING GMBHBIOVERATIV THERAPEUTICSInstitution Denied
IPR2018-01313Jul 2, 2018CSL BEHRING GMBHBIOVERATIV THERAPEUTICS INC.Institution Denied
IPR2017-01512May 31, 2017CSL BEHRING GMBHSHIRE VIROPHARMA INCORPORATEDInstitution Denied

Peer Comparison New

IP litigation analysis comparing Csl Behring Gmbh with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Aug 27, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
CSL BEHRING GMBH334 -
BIOVERATIV THERAPEUTICS - - - 2
BIOVERATIV THERAPEUTICS INC.23 - 2
SHIRE VIROPHARMA INCORPORATED - 3 - 2